NCT00403689View on ClinicalTrials.gov

Effects of (1,3), (1,6)-Beta-D-glucan on Insulin Sensitivity and Inflammatory Markers of the Metabolic Syndrome

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Overweight
Interventions
DIETARY_SUPPLEMENT

Beta-D-Glucan

1,5 g Beta-D-Glucan daily

DIETARY_SUPPLEMENT

placebo

1.5 g waxy maize starch daily

Trial Locations (1)

14558

German Institute of Human Nutrition, Department of Clinical Nutrition, Potsdam-Rehbrücke, Nuthetal

Sponsors
All Listed Sponsors
collaborator

Danone Research Foundation

UNKNOWN

collaborator

Leiber Company

UNKNOWN

lead

German Institute of Human Nutrition

OTHER